248 related articles for article (PubMed ID: 8017891)
1. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion.
Raine CS
Ann Neurol; 1994; 36 Suppl():S61-72. PubMed ID: 8017891
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis: immune system molecule expression in the central nervous system.
Raine CS
J Neuropathol Exp Neurol; 1994 Jul; 53(4):328-37. PubMed ID: 8021705
[TBL] [Abstract][Full Text] [Related]
3. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
4. Survival of oligodendrocytes in chronic relapsing experimental autoimmune encephalomyelitis.
Moore GR; Traugott U; Raine CS
J Neurol Sci; 1984 Aug; 65(2):137-45. PubMed ID: 6481396
[TBL] [Abstract][Full Text] [Related]
5. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
6. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies.
Martin R
J Neural Transm Suppl; 1997; 49():53-67. PubMed ID: 9266414
[TBL] [Abstract][Full Text] [Related]
7. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
[TBL] [Abstract][Full Text] [Related]
8. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination.
Merkler D; Ernsting T; Kerschensteiner M; Brück W; Stadelmann C
Brain; 2006 Aug; 129(Pt 8):1972-83. PubMed ID: 16714315
[TBL] [Abstract][Full Text] [Related]
9. The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion.
Raine CS
J Neuroimmunol; 1997 Aug; 77(2):135-52. PubMed ID: 9258244
[TBL] [Abstract][Full Text] [Related]
10. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
11. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis.
Bartlett PF; Mackay IR
J Clin Lab Immunol; 1983 May; 11(1):1-7. PubMed ID: 6348293
[TBL] [Abstract][Full Text] [Related]
12. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
Genain CP; Nguyen MH; Letvin NL; Pearl R; Davis RL; Adelman M; Lees MB; Linington C; Hauser SL
J Clin Invest; 1995 Dec; 96(6):2966-74. PubMed ID: 8675668
[TBL] [Abstract][Full Text] [Related]
13. Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis.
Kuerten S; Angelov DN
Ann Anat; 2008; 190(1):1-15. PubMed ID: 18342137
[TBL] [Abstract][Full Text] [Related]
14. Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
Mars LT; Saikali P; Liblau RS; Arbour N
Biochim Biophys Acta; 2011 Feb; 1812(2):151-61. PubMed ID: 20637863
[TBL] [Abstract][Full Text] [Related]
15. Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis.
Selmaj K; Brosnan CF; Raine CS
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6452-6. PubMed ID: 1830662
[TBL] [Abstract][Full Text] [Related]
16. Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis.
Lassmann H
J Neurol; 1983; 229(4):207-20. PubMed ID: 6192222
[TBL] [Abstract][Full Text] [Related]
17. Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.
Smith ME; Eller NL; McFarland HF; Racke MK; Raine CS
Am J Pathol; 1999 Oct; 155(4):1147-61. PubMed ID: 10514398
[TBL] [Abstract][Full Text] [Related]
18. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
[TBL] [Abstract][Full Text] [Related]
19. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Dittel BN
Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
[TBL] [Abstract][Full Text] [Related]
20. Deleterious versus protective autoimmunity in multiple sclerosis.
Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
